Your browser version may not work well with NCBI's Web applications. More information here...
1: Semin Nucl Med. 2005 Oct;35(4):257-65.Click here to read Links

Changing concepts in the management of differentiated thyroid cancer.

Intenzo CM, Jabbour S, Dam HQ, Capuzzi DM.

Division of Nuclear Medicine, Department of Radiology, Thomas Jefferson University, Philadelphia, PA 19107, USA. charles.intenzo@Jefferson.edu

The management of patients with differentiated thyroid cancer has changed significantly over the last few decades. Mortality has decreased as the result of earlier detection, refined surgical approaches, subsequent radioiodine ablation, and the development of more sensitive methods for detecting and monitoring disease recurrence. The latter has been facilitated by serum thyroglobulin measurements, the use of recombinant human thyrotropin, and the use of 18F-deoxyglucose/positron emission tomography in selected instances where radioiodine imaging fails to locate known or suspected recurrent or metastatic disease.

PMID: 16150246 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Thyroid (Armour® Thyroid)

    Thyroid is a hormone produced by the body. When taken correctly, thyroid is used to treat the symptoms of hypothyroidism (a condition where the thyroid gland does not produce enough thyroid hormone). Symptoms of hypothyr...

  • Source: AHFS Consumer Medication Information